Exelon
NDC 66758-144, rivastigmine, patch, extended release, from Sandoz Inc.
- Product NDC
- 66758-144
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022083
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66758-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE13.3 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66758-144-31 | 66758014431 | 30 PATCH in 1 CARTON (66758-144-31) / 24 h in 1 PATCH (66758-144-58) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b6ed6d15-116d-4596-92ce-3414574d7ba0
Use it
Look up 66758-144 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66758-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66758-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.